Skip to content

Skye Bioscience, Inc.: filings

Every Skye Bioscience, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 54 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 2026361080001628280-26-056968
10-Q2026-05-11fiscal Q1 202634720001628280-26-033417
10-K2026-03-10fiscal FY 202541840001628280-26-016394
10-Q2025-11-10fiscal Q3 2025331070001628280-25-051031
10-Q2025-08-07fiscal Q2 2025331030001516551-25-000049
10-Q2025-05-08fiscal Q1 202533710001516551-25-000042
10-K2025-03-20fiscal FY 202441840001516551-25-000027
10-Q2024-11-07fiscal Q3 2024371170001516551-24-000110
10-Q2024-08-09fiscal Q2 2024331030001516551-24-000070
10-Q2024-05-10fiscal Q1 202433700001516551-24-000055
10-K2024-03-22fiscal FY 202335720001516551-24-000048
10-Q2023-11-14fiscal Q3 2023341050001516551-23-000100
10-Q2023-08-07fiscal Q2 2023351040001516551-23-000044
10-Q2023-05-12fiscal Q1 202334710001516551-23-000041
10-K2023-03-31fiscal FY 202237760001516551-23-000038
10-Q2022-11-14fiscal Q3 2022381140001516551-22-000040
10-Q2022-08-15fiscal Q2 2022361080001516551-22-000022
10-Q2022-05-06fiscal Q1 202234720001516551-22-000006
10-K2022-03-28fiscal FY 202136730001516551-22-000004
10-Q2021-11-10fiscal Q3 2021381180001516551-21-000020
10-Q2021-08-06fiscal Q2 2021341050001628280-21-015972
10-Q2021-05-07fiscal Q1 202131670001628280-21-009446
10-K2021-03-02fiscal FY 202034680001640334-21-000483
10-Q2020-11-06fiscal Q3 2020331000001640334-20-002732
10-Q2020-08-13fiscal Q2 202033990001640334-20-002095
10-Q2020-05-08fiscal Q1 202029590001640334-20-001119
10-K2020-03-23fiscal FY 201933660001640334-20-000582
10-Q2019-11-14fiscal Q3 2019331020001640334-19-002291
10-Q2019-08-09fiscal Q2 201933970001640334-19-001572
10-Q2019-05-10fiscal Q1 201927540001640334-19-000805
10-K2019-03-14fiscal FY 201829600001640334-19-000379
10-Q2018-11-14fiscal Q3 201832860001640334-18-002123
10-Q2018-08-10fiscal Q2 201832870001640334-18-001536
10-Q2018-05-15fiscal Q1 201828550001640334-18-000968
10-K2018-03-19fiscal FY 201730600001640334-18-000482
10-Q2017-11-14fiscal Q3 201728800001640334-17-002417
10-Q2017-08-11fiscal Q2 201728810001640334-17-001627
10-Q2017-05-12fiscal Q1 201724490001640334-17-000931
10-K2017-03-10fiscal FY 201625520001640334-17-000456
10-Q2016-11-09fiscal Q3 201624640001640334-16-001933
10-Q2016-08-12fiscal Q2 201628800001640334-16-001531
10-Q2016-05-13fiscal Q1 201624490001640334-16-001069
10-K2016-03-21fiscal FY 201524510001640334-16-000847
10-Q2015-11-12fiscal Q3 201524620001640334-15-000301
10-Q2015-08-14fiscal Q2 201523550001640334-15-000037
10-Q2015-05-13fiscal Q1 201521390001557240-15-000300
10-K2015-03-27fiscal FY 201421330001557240-15-000195
10-Q2014-11-14fiscal Q3 201420380001557240-14-000691
10-Q2014-09-15fiscal Q3 201423630001557240-14-000510
10-Q2014-06-05fiscal Q2 201423620001557240-14-000313
10-Q2014-03-17fiscal Q1 201423480001557240-14-000144
10-K2014-01-27fiscal FY 201323420001557240-14-000036
10-Q2013-09-16fiscal Q3 201324690001557240-13-000264
10-Q2013-06-27fiscal Q2 201323670001557240-13-000182

Inspect the source

Entity
Skye Bioscience, Inc. / CIK 0001516551
Captured
2026-09-20T09:13:51.237Z
SEC response SHA-256
fd229875bbe9efbf8ce715b00820b845a594b6e60bad8dd4ff739bde7e7cfc9e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001516551.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))